StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis Operating Lease Assets by Quarter

Operating Lease Assets ($M)

QuarterlyAnnual

Novartis Operating Lease Assets: $1,649M in Q3 2026, up 8.8% from a year earlier.

Latest, Q3 2026
1,649
Period ended Sep 30, 2026
Change on a year earlier
+8.8%
1,515 in Q3 2025
History
32 quarters
Since Q4 2018
Sources
31
Documents cited below

Where the Q3 2026 figure comes from

“|| Right-of-use assets | 1 649 | 1 570”

Source: Novartis Form 6-K (0001114448-26-000014) ↗

Reported in Postgres DB + Form 6-K.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedOperating Lease Assets ($M)Year on yearSource
Q3 2026Sep 30, 20261,649+8.8%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2026Jun 30, 20261,582+9.4%Novartis 6-K (0001114448-26-000012, filed 2026-07-21) ↗
Q1 2026Mar 31, 20261,584+12.6%Novartis Form 6-K (0001114448-26-000010) ↗
Q4 2025Dec 31, 20251,570+11.0%Novartis 20-F (0001114448-26-000004, filed 2026-02-04) ↗
Q3 2025Sep 30, 20251,515+4.3%Novartis Form 6-K (0001114448-25-000003) ↗
Q2 2025Jun 30, 20251,446+5.7%Novartis 6-K (0001370368-25-000012, filed 2025-07-17) ↗
Q1 2025Mar 31, 20251,407+4.8%Novartis Form 6-K (0001370368-25-000010) ↗
Q4 2024Dec 31, 20241,415+0.4%Novartis 20-F (0001370368-25-000004, filed 2025-01-31) ↗
Q3 2024Sep 30, 20241,452+11.7%Novartis Form 6-K (0001370368-24-000022) ↗
Q2 2024Jun 30, 20241,368-5.8%Novartis 6-K (0001370368-24-000019, filed 2024-07-18) ↗
Q1 2024Mar 31, 20241,342-10.9%Novartis Form 6-K (0001370368-24-000017) ↗
Q4 2023Dec 31, 20231,410-1.5%Novartis 20-F (0001370368-24-000004, filed 2024-01-31) ↗
Q3 2023Sep 30, 20231,300-8.2%Novartis Form 6-K (0001370368-23-000068) ↗
Q2 2023Jun 30, 20231,452-1.4%Novartis 6-K (0001370368-23-000059, filed 2023-07-18) ↗
Q1 2023Mar 31, 20231,507-0.5%Novartis Form 6-K (0001370368-23-000046) ↗
Q4 2022Dec 31, 20221,431-8.3%Novartis 20-F (0001370368-23-000006, filed 2023-02-01) ↗

Cite this data

StockData. (2026). Novartis Operating Lease Assets ($M), quarterly Q4 2018–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/db-bs-rou

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.